P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST-IN-HUMAN STUDY OF INA03, AN ANTI-CD71 ANTIBODY-DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS
Sylvain Garciaz,
Pierre Bories,
Leonor Lopez Almeida,
Jean-Marie Boher,
Coralie Belanger,
Christian Recher,
Olivier Hermine,
Norbert Vey,
Pierre Launay
Affiliations
Sylvain Garciaz
1 Institut Paoli-Calmettes, Deparment of Hematology, MARSEILLE, France
Pierre Bories
2 Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Toulouse, Deparment of Hematology, Toulouse, France
Leonor Lopez Almeida
3 Institut Paoli-Calmettes, Department of Clinical Research and Innovation, MARSEILLE, France
Jean-Marie Boher
3 Institut Paoli-Calmettes, Department of Clinical Research and Innovation, MARSEILLE, France
Coralie Belanger
4 Inatherys, Evry, France
Christian Recher
2 Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Toulouse, Deparment of Hematology, Toulouse, France
Olivier Hermine
4 Inatherys, Evry, France
Norbert Vey
3 Institut Paoli-Calmettes, Department of Clinical Research and Innovation, MARSEILLE, France
